DRC Begins Ebola Vaccine Trial to Fight Bundibugyo Outbreak

Democratic Republic of the Congo Begins Historic Clinical Trial for Ebola Vaccine in Bunia

Health authorities administered the first dose of an experimental vaccine on October 23, 2026, in Bunia, the capital of Ituri province, marking a critical milestone in the Democratic Republic of the Congo’s fight against the seventeenth Ebola epidemic, allAfrica.fr reported. The outbreak, caused by the Bundibugyo species of the virus, has driven the national case count past 9,700 and claimed more than 4,600 lives since emerging in May 2026, according to figures shared by RTBF and Paris Match.

How the Tumaini Trial Evaluates Cross-Protection and New Candidates

Researchers are testing Ervebo—a vaccine previously approved only for the Zaire strain of Ebola—to determine if it provides cross-protection against the Bundibugyo variant, as detailed by RTBF. Steve Ahuka-Mundeke, the field response manager for the Ebola epidemic, emphasized that the study addresses urgent community needs while aiming to halt transmission and save lives, Lalibre reported. Paris Match noted that the trial framework will eventually incorporate two specific Bundibugyo candidate vaccines currently advancing through smaller clinical phases: an adenoviral vector vaccine designated ChAdOx1 from the University of Oxford and an mRNA candidate developed by Moderna.

Remaining Challenges and Unresolved Questions

Significant gaps separate current trial phases from the definitive regulatory approval of treatments for this specific strain, as no vaccines or specific therapeutics are yet licensed for Bundibugyo, according to allAfrica.fr and RTBF. Authorities face a continuing lethality rate of 48.2 percent alongside community resistance that requires sustained public awareness campaigns led by Félix Tshisekedi’s administration, allAfrica.fr reported. International partners including the United States and WHO agencies continue to finance and support containment efforts while researchers work to establish safety and immunogenicity data, allAfrica.fr and RTBF confirmed.

More on this story: DR Congo Ebola Outbreak Spreads to Eighth Province as Regional Cases Rise · Kenya Trials Remdesivir to Treat Rare Bundibugyo Ebola Strain

More on Ebola: Nigeria Confirms First Ebola Case in Abuja Linked to Uganda Travel · Uganda Imposes 21-Day Ebola Quarantine for Travelers from DRC · Nigeria Ebola Patient Travel Accounts Disputed by Health Officials